| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2023 ( Subtotal = $18,222,789 ) (Continued on the next page) |
| | 2023 | 2023 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01HL122124 | Mitochondria-SR Tethering: Its Role in Cardiac Bioenergetics and Ca2+ Dynamics | 001 | 6 | NIH | 3/21/2023 | $54,747 |
| | 2023 | 2023 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R03AI169437 | An animal model for cytomegalovirus-induced pathology in the developing retina | 000 | 2 | NIH | 1/17/2023 | $78,000 |
| | 2023 | 2023 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | F30DK127639 | Silencing the uroguanylin-GUCY2C gut-brain axis mediates leptin resistance in obesity | 000 | 3 | NIH | 1/11/2023 | $48,002 |
| | 2023 | 2023 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01MH116463 | mGluR5 hypoactivity is integral to glutamatergic dysregulation in schizophrenia | 000 | 5 | NIH | 1/19/2023 | $548,350 |
| | 2023 | 2023 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R21CA259750 | Contrast-Enhanced Ultrasound for Diagnosis and Therapy of Cholangiocarcinoma | 000 | 2 | NIH | 1/27/2023 | $178,679 |
| | 2023 | 2023 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01HL150019 | Cell type-specific function of LMNA during myocardial stress in the development of cardiomyopathy | 000 | 4 | NIH | 2/23/2023 | $390,000 |
| | 2023 | 2023 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AR074813 | Pathogenesis of Inflammation-driven Intervertebral Disc Herniation: The Role of Syndecan 4 | 000 | 5 | NIH | 1/25/2023 | $405,792 |
| | 2023 | 2023 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01EY021784 | Paradigms of maintaining anterior segment homeostasis | 001 | 12 | NIH | 3/3/2023 | $600,338 |
| | 2023 | 2023 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01ES033197 | METTL3 in chromium-induced angiogenesis and carcinogenesis | 000 | 2 | NIH | 1/26/2023 | $519,475 |
| | 2023 | 2023 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01NS111113 | Development of an MRI Template & Neuroimaging Biomarkers of the Pediatric Spinal Cord | 000 | 4 | NIH | 2/3/2023 | $551,023 |
| | 2023 | 2023 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AR074813 | Pathogenesis of Inflammation-driven Intervertebral Disc Herniation: The Role of Syndecan 4 | 001 | 5 | NIH | 2/17/2023 | $45,087 |
| | 2023 | 2023 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01HL093671 | Ca2+ and ROS Crosstalk Signaling in Cardiac Mitochondria | 000 | 12 | NIH | 11/16/2022 | $456,192 |
| | 2023 | 2023 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | UG1CA233341 | Sidney Kimmel Cancer Center LAPS Institutional Collaboration | 000 | 5 | NIH | 2/28/2023 | $398,464 |
| | 2023 | 2023 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01HL093671 | Ca2+ and ROS Crosstalk Signaling in Cardiac Mitochondria | 001 | 12 | NIH | 2/11/2023 | $50,688 |
| | 2023 | 2023 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R21AI168975 | Role of rRNA-derived short non-coding RNAs in innate immune response | 000 | 2 | NIH | 1/23/2023 | $195,000 |
| | 2023 | 2023 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AI146235 | T cell control of MCMV and tissue-localized immune suppression | 000 | 4 | NIH | 2/23/2023 | $563,467 |
| | 2023 | 2023 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R35GM134931 | tRNA in codon usage | 000 | 4 | NIH | 2/16/2023 | $546,000 |
| | 2023 | 2023 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AR074953 | NGF-TrkA Signaling in Load-Induced Bone Formation | 003 | 5 | NIH | 2/17/2023 | $34,320 |
| | 2023 | 2023 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01HL096686 | Targeting Adiponectin for Cardioprotection in the Ischemic Heart | 001 | 11 | NIH | 2/11/2023 | $39,023 |
| | 2023 | 2023 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA268899 | A novel strategy for transcriptional reprogramming of lymphoid leukemia cells | 000 | 2 | NIH | 2/10/2023 | $529,222 |
| | 2023 | 2023 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | U01AI148117 | Role of immune receptor clustering in controlling efficacy of antibody-dependent Fc?RIIIa-mediated cytotoxicity by NK cells | 000 | 4 | NIH | 1/12/2023 | $502,627 |
| | 2023 | 2023 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AR074953 | NGF-TrkA Signaling in Load-Induced Bone Formation | 001 | 5 | NIH | 1/18/2023 | $308,880 |
| | 2023 | 2023 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01HL096686 | Targeting Adiponectin for Cardioprotection in the Ischemic Heart | 000 | 11 | NIH | 1/12/2023 | $351,206 |
| | 2023 | 2023 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AG073349 | Epigenetic Mechanisms of Spontaneous Disc Degeneration in SM/J Mice | 000 | 2 | NIH | 2/23/2023 | $19,929 |
| | 2023 | 2023 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AI149795 | Pan-lyssavirus therapeutics and mechanisms of protection against lyssaviruses | 000 | 3 | NIH | 2/22/2023 | $390,000 |
| | 2023 | 2023 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01GM132611 | Regulation of inositol trisphosphate receptors | 001 | 4 | NIH | 2/16/2023 | $32,116 |
| | 2023 | 2023 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA222847 | Statistical Methods For Quantitative Immunohistochemistry Biomarkers | 000 | 5 | NIH | 1/31/2023 | $348,458 |
| | 2023 | 2023 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AR074564 | Regulation of the Cell Death Program by DFNA5 | 001 | 5 | NIH | 2/16/2023 | $53,754 |
| | 2023 | 2023 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AG065467 | Health Beliefs, Glycemic Control, and Preventing Cognitive Decline in African Americans with Diabetes and Mild Cognitive Impairment: A Randomized Clinical Trial | 000 | 4 | NIH | 2/15/2023 | $757,048 |
| | 2023 | 2023 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01GM132611 | Regulation of inositol trisphosphate receptors | 000 | 4 | NIH | 1/13/2023 | $289,046 |
| | 2023 | 2023 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AR074564 | Regulation of the Cell Death Program by DFNA5 | 000 | 5 | NIH | 11/8/2022 | $483,785 |
| | 2023 | 2023 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AR055655 | Role of HIF-1 in Intervertebral Disc Function | 000 | 15 | NIH | 2/24/2023 | $522,466 |
| | 2023 | 2023 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AI141787 | Local?immune?tolerance?in?the?large?intestine?mediated?by?GPR15 | 000 | 4 | NIH | 1/11/2023 | $546,983 |
| | 2023 | 2023 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA226432 | Replication stress in hematopoiesis and lymphomagenesis | 001 | 5 | NIH | 3/15/2023 | $34,241 |
| | 2023 | 2023 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AI144081 | How chlamydia generates cytoskeletal scaffolds and their role during infection | 000 | 5 | NIH | 1/18/2023 | $390,000 |
| | 2023 | 2023 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01GM138943 | Regulation of Mutationally Activated Gq/11 | 001 | 3 | NIH | 2/13/2023 | $31,200 |
| | 2023 | 2023 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01GM138943 | Regulation of Mutationally Activated Gq/11 | 000 | 3 | NIH | 1/13/2023 | $280,800 |
| | 2023 | 2023 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA236853 | BCLW in lymphoma survival and resistance to targeted BCL2 family therapies | 000 | 4 | NIH | 2/1/2023 | $112,885 |
| | 2023 | 2023 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01HL164941 | Crosstalk Ca2+ Signaling between Ryanodine Receptors Type 1 and 2 in the Pathogenesis of Cardiac Hypertrophy and Heart Failure | 000 | 1 | NIH | 3/9/2023 | $582,440 |
| | 2023 | 2023 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01DK125897 | ER-mitochondrial communication in calcium signaling, energy metabolism and liver disease | 000 | 3 | NIH | 2/23/2023 | $472,507 |
| | 2023 | 2023 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01NS115441 | Novel mechanisms regulating protein interaction and pain | 001 | 4 | NIH | 1/31/2023 | $51,413 |
| | 2023 | 2023 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01NS115441 | Novel mechanisms regulating protein interaction and pain | 000 | 4 | NIH | 11/25/2022 | $462,722 |
| | 2023 | 2023 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01EY026478 | Regulatory role of PI3K signaling pathways in lens differentiation and function | 000 | 8 | NIH | 2/24/2023 | $518,305 |
| | 2023 | 2023 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | F30NS130973 | Determining the cellular and nanoscale localization of Synaptotagmin VII | 002 | 1 | NIH | 2/10/2023 | $942 |
| | 2023 | 2023 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | F30NS130973 | Determining the cellular and nanoscale localization of Synaptotagmin VII | 000 | 1 | NIH | 12/5/2022 | $48,027 |
| | 2023 | 2023 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA236857 | Development of a Novel Lung Function Imaging Modality for comprehensive management of lung cancer | 000 | 5 | NIH | 1/31/2023 | $394,941 |
| | 2023 | 2023 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA199646 | Optimizing Ultrasound Enhanced Delivery of Therapeutics | 000 | 7 | NIH | 3/16/2023 | $388,631 |
| | 2023 | 2023 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | F30NS130973 | Determining the cellular and nanoscale localization of Synaptotagmin VII | 001 | 1 | NIH | 12/5/2022 | $0 |
| | 2023 | 2023 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R21AI173837 | Skin-homing Group-1 innate lymphoid cells in viral defense | 000 | 1 | NIH | 11/10/2022 | $234,000 |
|
